Plasmid DNA Manufacture: Setting Expectations of Service With Your Clinical Supply Partner
A successful CDMO manufacturing partnership requires starting with the end in mind, with consideration for the intended use of the pDNA either as a critical starting / ancillary material for further processing, a mRNA template or plasmid for transfection to generate viral vectors, or drug substance as a gene therapy. You can read more about Plasmid DNA Manufacture: Setting Expectations of Service with Your Clinical Supply Partner by downloading this resource here
